1. Home
  2. CVKD vs HIHO Comparison

CVKD vs HIHO Comparison

Compare CVKD & HIHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • HIHO
  • Stock Information
  • Founded
  • CVKD 2022
  • HIHO 1990
  • Country
  • CVKD United States
  • HIHO Hong Kong
  • Employees
  • CVKD N/A
  • HIHO N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • HIHO Industrial Machinery/Components
  • Sector
  • CVKD Health Care
  • HIHO Industrials
  • Exchange
  • CVKD Nasdaq
  • HIHO Nasdaq
  • Market Cap
  • CVKD 6.9M
  • HIHO 8.2M
  • IPO Year
  • CVKD 2023
  • HIHO 1996
  • Fundamental
  • Price
  • CVKD $12.00
  • HIHO $1.86
  • Analyst Decision
  • CVKD Strong Buy
  • HIHO
  • Analyst Count
  • CVKD 2
  • HIHO 0
  • Target Price
  • CVKD $52.50
  • HIHO N/A
  • AVG Volume (30 Days)
  • CVKD 44.9K
  • HIHO 6.6K
  • Earning Date
  • CVKD 11-08-2024
  • HIHO 10-21-2024
  • Dividend Yield
  • CVKD N/A
  • HIHO 3.78%
  • EPS Growth
  • CVKD N/A
  • HIHO N/A
  • EPS
  • CVKD N/A
  • HIHO N/A
  • Revenue
  • CVKD N/A
  • HIHO $6,853,000.00
  • Revenue This Year
  • CVKD N/A
  • HIHO N/A
  • Revenue Next Year
  • CVKD N/A
  • HIHO N/A
  • P/E Ratio
  • CVKD N/A
  • HIHO N/A
  • Revenue Growth
  • CVKD N/A
  • HIHO N/A
  • 52 Week Low
  • CVKD $5.40
  • HIHO $1.70
  • 52 Week High
  • CVKD $32.55
  • HIHO $2.36
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 55.95
  • HIHO 46.92
  • Support Level
  • CVKD $11.00
  • HIHO $1.86
  • Resistance Level
  • CVKD $15.37
  • HIHO $2.00
  • Average True Range (ATR)
  • CVKD 1.43
  • HIHO 0.06
  • MACD
  • CVKD -0.16
  • HIHO 0.00
  • Stochastic Oscillator
  • CVKD 37.26
  • HIHO 22.22

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.

Share on Social Networks: